This document contains information on 56 batches of products produced including Doxofylline, Itopride, Deferasirox, Rosuvastatin, and Atomoxitine. It lists the product name, batch size, stage, batch number, effluent quantity produced, and for some batches, the reactors taken for cleaning and effluent from reactor cleaning. The total effluent quantity produced for all batches is 33,152. The largest contributors to this total are Itopride batches, which produced 24,693 effluent quantity, and Deferasirox, which produced 7,960 effluent quantity.
This document contains information on 56 batches of products produced including Doxofylline, Itopride, Deferasirox, Rosuvastatin, and Atomoxitine. It lists the product name, batch size, stage, batch number, effluent quantity produced, and for some batches, the reactors taken for cleaning and effluent from reactor cleaning. The total effluent quantity produced for all batches is 33,152. The largest contributors to this total are Itopride batches, which produced 24,693 effluent quantity, and Deferasirox, which produced 7,960 effluent quantity.
This document contains information on 56 batches of products produced including Doxofylline, Itopride, Deferasirox, Rosuvastatin, and Atomoxitine. It lists the product name, batch size, stage, batch number, effluent quantity produced, and for some batches, the reactors taken for cleaning and effluent from reactor cleaning. The total effluent quantity produced for all batches is 33,152. The largest contributors to this total are Itopride batches, which produced 24,693 effluent quantity, and Deferasirox, which produced 7,960 effluent quantity.